do morphological alterations of peripheral white blood cells have predictive value in progression of hiv-disease?

NLM AIDSLINE Do morphological alterations of peripheral white blood cells have predictive value in progression of HIV-disease? Duray E; Regius O; Horvath A; Semmelweis Med. Univ. Geront. Ins.
December 30, 1992

Int Conf AIDS. 1992 Jul 19-24;8(3):75 (abstract no. PuB 7157). Unique OBJECTIVES: Aim of the study was to compare morphological alterations of peripheral white blood cells from HIV positive and negative male homosexuals with abnormalities of cellular immunoresponse, characteristics of sexual behaviour and clinical status. METHODS: Study population was 35 HIV positive and 19 HIV negative male homosexuals. Separated peripheral white blood cells/lymphocytes, eosinophils and polymorphonuclear leukocytes/ were examined electronmicroscopically. Three categories of morphological alterations were detected: 1. cytoplasm degenerations/tubuloreticular inclusions/TRI/, nucleus degenerations/invaginations/and mitochondrial degenerations/myelin-like structures, giant mitochondrias/. Total number and ratio of CD4 positive and CD8 positive cells were investigated by immunofluorescent method, using monoclonal antibodies. Clinical status were set after the criteria of CDC. RESULTS: Incidence of three sort of cell morphological abnormalities was significantly higher in the HIV infected group. Appearance of TRI in lymphocytes and multiple lymphocyte degenerative alterations showed positive correlation with CDC-stadium. CONCLUSION: Presence of tubuloreticular inclusions in peripheral blood lymphocytes from HIV infected homosexuals has a predictive value in clinical prognosis. Human HIV Infections/BLOOD HIV Seropositivity/BLOOD Lymphocytes/ULTRASTRUCTURE Male Prognosis ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance CONNECTICUT: At Hartford Public High School, A Day Reserved for 'Healthy Relationships' ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment KENYA: Kenya Launches Universal HPV Vaccine Access to Youths UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial) OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial)Navajo Confront an Increase in New H.I.V. Infections TB, HIV and malaria vaccine research gets major boost Measuring hidden HIV Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
Information in this article was accurate in December 30, 1992. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.